Exact Mass: 249.0848

Exact Mass Matches: 249.0848

Found 172 metabolites which its exact mass value is equals to given mass value 249.0848, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

S-Acetyldihydrolipoamide

S-[6-Amino-6-oxo-1-(2-sulfanylethyl)hexyl] ethanethioic acid

C10H19NO2S2 (249.0857)


S-Acetyldihydrolipoamide is a thio-acetylated form of dihydrolipoamide. The molecule is commonly conjugated to lysine residues. The structure shown is the free form of the molecule. Pyruvate dehydrogenase complex. The reaction is 2-(alpha-hydroxyethyl)-TPP + lipoamide => S-acetyldihydrolipoamide + TPP [Homo sapiens], occuring in mitochondrial matrix. (reactome.org). S-Acetyldihydrolipoamide is an intermediate in alanine, aspartate and pyruvate metabolism and glycolysis/gluconeogenesis (KEGG:C01136). It is converted from 2-hydroxyethyl-THPP and lipoamide via the enzyme pyruvate dehydrogenase (EC:1.2.4.1). It is then converted to acetyl-CoA via the enzyme pyruvate dehydrogenase E2 component (dihydrolipoamide acetyltransferase) (EC:2.3.1.12). S-Acetyldihydrolipoamide is a thio-acetylated form of dihydrolipoamide. The molecule is commonly conjugated to lysine residues. The structure shown is the free form of the molecule.

   
   

Phenazopyridine hydrochloride

Phenazopyridine hydrochloride

C11H12ClN5 (249.0781)


   

Cysteinyl-Glutamine

2-[(2-Amino-1-hydroxy-3-sulphanylpropylidene)amino]-4-(C-hydroxycarbonimidoyl)butanoic acid

C8H15N3O4S (249.0783)


Cysteinyl-Glutamine is a dipeptide composed of cysteine and glutamine. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis. This dipeptide has not yet been identified in human tissues or biofluids and so it is classified as an Expected metabolite.

   

Glutaminylcysteine

(2R)-2-{[(2S)-2-amino-1-hydroxy-4-(C-hydroxycarbonimidoyl)butylidene]amino}-3-sulphanylpropanoic acid

C8H15N3O4S (249.0783)


Glutaminylcysteine is a dipeptide composed of glutamine and cysteine. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis.

   

S-Acetyldihydrolipoamide-E

Dihydrolipoyllysine-residue acetyltransferase]S-acetyldihydrolipoyllysine

C10H19NO2S2 (249.0857)


The acetyl thioester of the reduced lipoyllysine residue in dihydrolipoyllysine-residue acetyltransferase (EC2.3.1.12). S-Acetyldihydrolipoamide-E is a reactant or product of enzyme EC 1.2.4.1. S-Acetyldihydrolipoamide-E is a reactant or product of enzyme EC 2.3.1.12. (PubChem sid=47205563) [HMDB] The acetyl thioester of the reduced lipoyllysine residue in dihydrolipoyllysine-residue acetyltransferase (EC2.3.1.12). S-Acetyldihydrolipoamide-E is a reactant or product of enzyme EC 1.2.4.1. S-Acetyldihydrolipoamide-E is a reactant or product of enzyme EC 2.3.1.12. (PubChem sid=47205563).

   

Cysteinyl-Gamma-glutamate

2-Amino-4-[(2-amino-3-sulphanylpropanoyl)-C-hydroxycarbonimidoyl]butanoic acid

C8H15N3O4S (249.0783)


Cysteinyl-Gamma-glutamate is a dipeptide composed of cysteine and gamma-glutamate. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis. This dipeptide has not yet been identified in human tissues or biofluids and so it is classified as an Expected metabolite.

   

(1Z)-1-(3-Ethyl-5-methoxy-1,3-benzothiazol-2-ylidene)propan-2-one

1-(3-ethyl-5-methoxy-2,3-dihydro-1,3-benzothiazol-2-ylidene)propan-2-one

C13H15NO2S (249.0823)


   

1-(2-Pyridylazo)-2-naphthol

1-[2-(pyridin-2-yl)diazen-1-yl]naphthalen-2-ol

C15H11N3O (249.0902)


   

4-Nitro-7-piperazinobenzofurazan

4-nitro-7-(piperazin-1-yl)-2,1,3-benzoxadiazole

C10H11N5O3 (249.0862)


   

2',3'-Didehydro-2',3'-dideoxyguanosine

2-amino-9-[5-(hydroxymethyl)-2,5-dihydrofuran-2-yl]-6,9-dihydro-1H-purin-6-one

C10H11N5O3 (249.0862)


   

6-Nitrotryptophan

2-amino-3-(6-nitro-1H-indol-3-yl)propanoic acid

C11H11N3O4 (249.075)


   

Benzo(f)quinolin-3(2H)-one, 8-chloro-1,4,4a,5,6,10b-hexahydro-4-methyl-, trans-

Benzo(f)quinolin-3(2H)-one, 8-chloro-1,4,4a,5,6,10b-hexahydro-4-methyl-, trans-

C14H16ClNO (249.092)


   

Ala-Cys-Gly

2-[[2-(2-Aminopropanoylamino)-3-sulfanylpropanoyl]amino]acetic acid

C8H15N3O4S (249.0783)


   

(E)-3-(4-Tert-butylphenylsulfonyl)acrylonitrile

3-(4-Tert-butylphenyl)sulphonyl-2-propenenitrile

C13H15NO2S (249.0823)


   

Cinchophen

2-phenylquinoline-4-carboxylic acid

C16H11NO2 (249.079)


M - Musculo-skeletal system > M04 - Antigout preparations > M04A - Antigout preparations > M04AC - Preparations with no effect on uric acid metabolism C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic

   

Nitrotryptophan

3-(1H-indol-3-yl)-2-(nitroamino)propanoic acid

C11H11N3O4 (249.075)


   

TVP-1022

N-(2,3-Dihydro-1H-inden-1-yl)-N-(prop-2-yn-1-yl)methanesulphonamide

C13H15NO2S (249.0823)


   

Maybridge3_001100

Maybridge3_001100

C12H15N3OS (249.0936)


   

Me glycoside,N-Ac-alpha-D-Pyranose-4-Amino-4-deoxyglucuronic acid

Me glycoside,N-Ac-alpha-D-Pyranose-4-Amino-4-deoxyglucuronic acid

C9H15NO7 (249.0848)


   
   

2-Anilino-1,4-naphthoquinone

2-Anilino-1,4-naphthoquinone

C16H11NO2 (249.079)


   

HeptaohylloneB

HeptaohylloneB

C16H11NO2 (249.079)


   

Dehydroanhydrolycorine

Dehydroanhydrolycorine

C16H11NO2 (249.079)


   
   
   

5-Acetamido-3,5-didesoxy-L-arabino-heptulonsaeure

5-Acetamido-3,5-didesoxy-L-arabino-heptulonsaeure

C9H15NO7 (249.0848)


   
   
   

Cinchophen

Cinchophen

C16H11NO2 (249.079)


M - Musculo-skeletal system > M04 - Antigout preparations > M04A - Antigout preparations > M04AC - Preparations with no effect on uric acid metabolism C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic CONFIDENCE standard compound; INTERNAL_ID 1051; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4523; ORIGINAL_PRECURSOR_SCAN_NO 4519 CONFIDENCE standard compound; INTERNAL_ID 1051; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4546; ORIGINAL_PRECURSOR_SCAN_NO 4543 CONFIDENCE standard compound; INTERNAL_ID 1051; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4500; ORIGINAL_PRECURSOR_SCAN_NO 4498 CONFIDENCE standard compound; INTERNAL_ID 1051; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4520; ORIGINAL_PRECURSOR_SCAN_NO 4516 CONFIDENCE standard compound; INTERNAL_ID 1051; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4555; ORIGINAL_PRECURSOR_SCAN_NO 4552 CONFIDENCE standard compound; INTERNAL_ID 1051; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4546; ORIGINAL_PRECURSOR_SCAN_NO 4545 CONFIDENCE standard compound; INTERNAL_ID 1051; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8905; ORIGINAL_PRECURSOR_SCAN_NO 8900 CONFIDENCE standard compound; INTERNAL_ID 1051; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8921; ORIGINAL_PRECURSOR_SCAN_NO 8919 CONFIDENCE standard compound; INTERNAL_ID 1051; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8942; ORIGINAL_PRECURSOR_SCAN_NO 8939 CONFIDENCE standard compound; INTERNAL_ID 1051; DATASET 20200303_ENTACT_RP_MIX503; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8878; ORIGINAL_PRECURSOR_SCAN_NO 8876 CONFIDENCE standard compound; INTERNAL_ID 1051; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8996; ORIGINAL_PRECURSOR_SCAN_NO 8993 CONFIDENCE standard compound; INTERNAL_ID 1051; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8968; ORIGINAL_PRECURSOR_SCAN_NO 8966

   
   
   
   
   
   
   
   
   

S-Acetyldihydrolipoamide-E

Dihydrolipoyllysine-residue acetyltransferase]S-acetyldihydrolipoyllysine

C10H19NO2S2 (249.0857)


   

Cys-GLN

2-(2-amino-4-carbamoylbutanamido)-3-sulfanylpropanoic acid

C8H15N3O4S (249.0783)


   

Cys-gglu

2-[2-amino-4-(C-hydroxycarbonimidoyl)butanamido]-3-sulfanylpropanoic acid

C8H15N3O4S (249.0783)


   

GLN-Cys

2-(2-amino-3-sulfanylpropanamido)-4-carbamoylbutanoic acid

C8H15N3O4S (249.0783)


   

GGlu-Cys

2-(2-amino-3-sulfanylpropanamido)-4-(C-hydroxycarbonimidoyl)butanoic acid

C8H15N3O4S (249.0783)


   

S-acetyldihydrolipoamide

6-(acetylsulfanyl)-8-sulfanyloctanamide

C10H19NO2S2 (249.0857)


   

ART-CHEM-BB B018075

ART-CHEM-BB B018075

C12H15N3OS (249.0936)


   

(S)-(+)-3-HYDROXYBUTYRONITRILE

(S)-(+)-3-HYDROXYBUTYRONITRILE

C10H11N5O3 (249.0862)


   

4-[4-(TERT-BUTYL)PHENYL]-5-MERCAPTO-2,4-DIHYDRO-3H-1,2,4-TRIAZOL-3-ONE

4-[4-(TERT-BUTYL)PHENYL]-5-MERCAPTO-2,4-DIHYDRO-3H-1,2,4-TRIAZOL-3-ONE

C12H15N3OS (249.0936)


   

1-CHLORO-3-(1,3,3-TRIMETHYL-1,3-DIHYDRO-INDOL-2-YLIDENE)-PROPAN-2-ONE

1-CHLORO-3-(1,3,3-TRIMETHYL-1,3-DIHYDRO-INDOL-2-YLIDENE)-PROPAN-2-ONE

C14H16ClNO (249.092)


   

3-METHOXY-4-PYRROLIDIN-1-YL-BENZALDEHYDE

3-METHOXY-4-PYRROLIDIN-1-YL-BENZALDEHYDE

C12H15N3OS (249.0936)


   
   

(r)-(-)-nbd-apy

(r)-(-)-nbd-apy

C10H11N5O3 (249.0862)


   

ART-CHEM-BB B018083

ART-CHEM-BB B018083

C12H15N3OS (249.0936)


   

Ethyl 3,7-dimethyl-4H-benzo[1,4]thiazine-2-carboxylate

Ethyl 3,7-dimethyl-4H-benzo[1,4]thiazine-2-carboxylate

C13H15NO2S (249.0823)


   

2,2:6,2-terpyridine N-oxide

2,2:6,2-terpyridine N-oxide

C15H11N3O (249.0902)


   

2-METHYL-6-NITRO-IMIDAZO[1,2-A]PYRIDINE-3-CARBOXYLIC ACID ETHYL ESTER

2-METHYL-6-NITRO-IMIDAZO[1,2-A]PYRIDINE-3-CARBOXYLIC ACID ETHYL ESTER

C11H11N3O4 (249.075)


   

Bay H 2049

Daniquidone

C15H11N3O (249.0902)


C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor > C1748 - Topoisomerase Inhibitor

   

Phenol,2-[[(phenylmethyl)amino]methyl]-, hydrochloride (1:1)

Phenol,2-[[(phenylmethyl)amino]methyl]-, hydrochloride (1:1)

C14H16ClNO (249.092)


   

1400W dihydrochloride

1400W dihydrochloride

C10H17Cl2N3 (249.0799)


   

methyl 1,3-dimethyl-2,4-dioxo-1,2,3,4-tetrahydropyrido[2,3-d]pyrimidine-6-carboxylate

methyl 1,3-dimethyl-2,4-dioxo-1,2,3,4-tetrahydropyrido[2,3-d]pyrimidine-6-carboxylate

C11H11N3O4 (249.075)


   

ART-CHEM-BB B018142

ART-CHEM-BB B018142

C12H15N3OS (249.0936)


   

(1-thieno[3,2-d]pyrimidin-4-ylpiperidin-4-yl)methanol

(1-thieno[3,2-d]pyrimidin-4-ylpiperidin-4-yl)methanol

C12H15N3OS (249.0936)


   

ART-CHEM-BB B018098

ART-CHEM-BB B018098

C12H15N3OS (249.0936)


   

ART-CHEM-BB B018020

ART-CHEM-BB B018020

C12H15N3OS (249.0936)


   

1-PHENYL-3-PYRIDIN-3-YL-1H-PYRAZOLE-4-CARBALDEHYDE

1-PHENYL-3-PYRIDIN-3-YL-1H-PYRAZOLE-4-CARBALDEHYDE

C15H11N3O (249.0902)


   

4-benzylidene-2-phenyl-2-oxazolin-5-one

4-benzylidene-2-phenyl-2-oxazolin-5-one

C16H11NO2 (249.079)


   

(4-methoxyphenyl)(phenyl)methanamine hydrochloride

(4-methoxyphenyl)(phenyl)methanamine hydrochloride

C14H16ClNO (249.092)


   

2-(3-hydroxyphenyl)-6-methyl-1,3,6,2-dioxazaborocane-4,8-dione

2-(3-hydroxyphenyl)-6-methyl-1,3,6,2-dioxazaborocane-4,8-dione

C11H12BNO5 (249.0808)


   

ETHYL5-AMINO-1-(2-FLUOROPHENYL)-1H-PYRAZOLE-3-CARBOXYLATE

ETHYL5-AMINO-1-(2-FLUOROPHENYL)-1H-PYRAZOLE-3-CARBOXYLATE

C12H12FN3O2 (249.0914)


   

ethyl 5-amino-1-(4-fluorophenyl)pyrazole-4-carboxylate

ethyl 5-amino-1-(4-fluorophenyl)pyrazole-4-carboxylate

C12H12FN3O2 (249.0914)


   

3-(4-Fluorophenyl)-5-methyl-4-isoxazolecarboxylic acid ethyl ester

3-(4-Fluorophenyl)-5-methyl-4-isoxazolecarboxylic acid ethyl ester

C13H12FNO3 (249.0801)


   

4-(Benzyloxy)-3-methylaniline hydrochloride

4-(Benzyloxy)-3-methylaniline hydrochloride

C14H16ClNO (249.092)


   

6-Nitro-1H-benzimidazole-2-acetic acid ethyl ester

6-Nitro-1H-benzimidazole-2-acetic acid ethyl ester

C11H11N3O4 (249.075)


   

6-(1-chloroethyl)-2-N-phenyl-1,3,5-triazine-2,4-diamine

6-(1-chloroethyl)-2-N-phenyl-1,3,5-triazine-2,4-diamine

C11H12ClN5 (249.0781)


   

ethyl 6-amino-4-nitro-1H-indole-2-carboxylate

ethyl 6-amino-4-nitro-1H-indole-2-carboxylate

C11H11N3O4 (249.075)


   

ethyl 4-amino-6-nitro-1H-indole-2-carboxylate

ethyl 4-amino-6-nitro-1H-indole-2-carboxylate

C11H11N3O4 (249.075)


   

Bay 11-7085

(E)-3-(4-Tert-butylphenylsulfonyl)acrylonitrile

C13H15NO2S (249.0823)


   

2,3-Anhydroadenosine

2,3-Anhydroadenosine

C10H11N5O3 (249.0862)


   

3-phenethyloxyaniline

3-phenethyloxyaniline

C14H16ClNO (249.092)


   

1,3,5-Triazin-2(1H)-one, 4,6-diphenyl-

1,3,5-Triazin-2(1H)-one, 4,6-diphenyl-

C15H11N3O (249.0902)


   

2-Isopropoxy-5-(trifluoromethyl)pyridine-3-boronic acid

2-Isopropoxy-5-(trifluoromethyl)pyridine-3-boronic acid

C9H11BF3NO3 (249.0784)


   

[4-(4-methylphenoxy)phenyl]methanamine,hydrochloride

[4-(4-methylphenoxy)phenyl]methanamine,hydrochloride

C14H16ClNO (249.092)


   

ETHYL5-AMINO-1-(3-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXYLATE

ETHYL5-AMINO-1-(3-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXYLATE

C12H12FN3O2 (249.0914)


   

4-Nitro-7-piperazinobenzofurazan

4-nitro-7-piperazino-2,1,3-benzoxadiazole

C10H11N5O3 (249.0862)


   

8,5(S)-CYCLO-2-DEOXYADENOSINE

8,5(S)-CYCLO-2-DEOXYADENOSINE

C10H11N5O3 (249.0862)


   

5-deoxy-8,5-cycloadenosine

5-deoxy-8,5-cycloadenosine

C10H11N5O3 (249.0862)


   

ART-CHEM-BB B018080

ART-CHEM-BB B018080

C12H15N3OS (249.0936)


   

5-ethoxy-2-(4-nitrophenyl)-4H-pyrazol-3-one

5-ethoxy-2-(4-nitrophenyl)-4H-pyrazol-3-one

C11H11N3O4 (249.075)


   

2,6-Bis(2-pyridyl)-4(1H)-pyridone

2,6-Bis(2-pyridyl)-4(1H)-pyridone

C15H11N3O (249.0902)


   

ethyl 2-cyano-2-(4-methyl-3-nitropyridin-2-yl)acetate

ethyl 2-cyano-2-(4-methyl-3-nitropyridin-2-yl)acetate

C11H11N3O4 (249.075)


   

3,6-DIPHENYL-1,2,4-TRIAZIN-5-OL

3,6-DIPHENYL-1,2,4-TRIAZIN-5-OL

C15H11N3O (249.0902)


   

ETHYL5-AMINO-1-(2-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXYLATE

ETHYL5-AMINO-1-(2-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXYLATE

C12H12FN3O2 (249.0914)


   

2-AMINO-BENZOTHIAZOLE-6-CARBOXYLIC ACID SEC-BUTYLAMIDE

2-AMINO-BENZOTHIAZOLE-6-CARBOXYLIC ACID SEC-BUTYLAMIDE

C12H15N3OS (249.0936)


   

4-ethyl-3-[(2-methylphenoxy)methyl]-1H-1,2,4-triazole-5-thione

4-ethyl-3-[(2-methylphenoxy)methyl]-1H-1,2,4-triazole-5-thione

C12H15N3OS (249.0936)


   

4-ETHYL-5-[(4-METHYLPHENOXY)METHYL]-4H-1,2,4-TRIAZOLE-3-THIOL

4-ETHYL-5-[(4-METHYLPHENOXY)METHYL]-4H-1,2,4-TRIAZOLE-3-THIOL

C12H15N3OS (249.0936)


   

ART-CHEM-BB B018086

ART-CHEM-BB B018086

C12H15N3OS (249.0936)


   

4-ethyl-3-(1-phenoxyethyl)-1H-1,2,4-triazole-5-thione

4-ethyl-3-(1-phenoxyethyl)-1H-1,2,4-triazole-5-thione

C12H15N3OS (249.0936)


   

2-(4-Phenoxyphenyl)ethanamine hydrochloride (1:1)

2-(4-Phenoxyphenyl)ethanamine hydrochloride (1:1)

C14H16ClNO (249.092)


   

Benzoxiquine

8-Quinolinol,8-benzoate

C16H11NO2 (249.079)


C254 - Anti-Infective Agent > C28394 - Topical Anti-Infective Agent

   

2-METHYL-OXAZOLE-4-CARBOXYLICACIDMETHYLESTER

2-METHYL-OXAZOLE-4-CARBOXYLICACIDMETHYLESTER

C14H16ClNO (249.092)


   

4-(2-TRIFLUOROMETHYL-PHENOXY)-PIPERIDINEHYDROCHLORIDE

4-(2-TRIFLUOROMETHYL-PHENOXY)-PIPERIDINEHYDROCHLORIDE

C14H16ClNO (249.092)


   

4-(2-AMINOETHYL)BENZOICACIDHYDROCHLORIDE

4-(2-AMINOETHYL)BENZOICACIDHYDROCHLORIDE

C14H16ClNO (249.092)


   

5(4H)-Oxazolone,2-phenyl-4-(phenylmethylene)-

5(4H)-Oxazolone,2-phenyl-4-(phenylmethylene)-

C16H11NO2 (249.079)


   

(3-(BENZYLOXY)PHENYL)METHANAMINE

(3-(BENZYLOXY)PHENYL)METHANAMINE

C14H16ClNO (249.092)


   

6-(chloromethyl)-2-N-(4-methylphenyl)-1,3,5-triazine-2,4-diamine

6-(chloromethyl)-2-N-(4-methylphenyl)-1,3,5-triazine-2,4-diamine

C11H12ClN5 (249.0781)


   

3-(4-METHYLPHENOXY)BENZYLAMINE HYDROCHLORIDE

3-(4-METHYLPHENOXY)BENZYLAMINE HYDROCHLORIDE

C14H16ClNO (249.092)


   

1-PHENYL-3-PYRIDIN-4-YL-1H-PYRAZOLE-4-CARBALDEHYDE

1-PHENYL-3-PYRIDIN-4-YL-1H-PYRAZOLE-4-CARBALDEHYDE

C15H11N3O (249.0902)


   

ART-CHEM-BB B018139

ART-CHEM-BB B018139

C12H15N3OS (249.0936)


   

ART-CHEM-BB B018136

ART-CHEM-BB B018136

C12H15N3OS (249.0936)


   

1,2,4-Triazin-3(2H)-one,5,6-diphenyl-

1,2,4-Triazin-3(2H)-one,5,6-diphenyl-

C15H11N3O (249.0902)


   

4-(2,3-dimethylphenoxy)aniline

4-(2,3-dimethylphenoxy)aniline

C14H16ClNO (249.092)


   

1-ACETYL-2-BUTYL-5-CHLOROINDOLE

1-ACETYL-2-BUTYL-5-CHLOROINDOLE

C14H16ClNO (249.092)


   

7-(BENZYLOXY)-1H-INDAZOLE-3-CARBONITRILE

7-(BENZYLOXY)-1H-INDAZOLE-3-CARBONITRILE

C15H11N3O (249.0902)


   

(S)-4,9-DIHYDRO-1-METHYL-3H-PYRIDO[3,4-B]INDOLE-3-CARBOXYLICACID

(S)-4,9-DIHYDRO-1-METHYL-3H-PYRIDO[3,4-B]INDOLE-3-CARBOXYLICACID

C13H15NO2S (249.0823)


   

1-(3-HYDROXYPHENYL)-1-METHOXY-1-(2-THIAZOLYL)-PROPANE

1-(3-HYDROXYPHENYL)-1-METHOXY-1-(2-THIAZOLYL)-PROPANE

C13H15NO2S (249.0823)


   

1-(3-fluoro-5-trifluoromethylpyridin-2-yl)piperazine

1-(3-fluoro-5-trifluoromethylpyridin-2-yl)piperazine

C10H11F4N3 (249.0889)


   

1-(6-(quinoxalin-2-yl)pyridin-2-yl)ethanone

1-(6-(quinoxalin-2-yl)pyridin-2-yl)ethanone

C15H11N3O (249.0902)


   

1-PYRIDIN-2-YL-[1,4]DIAZEPANE DIHYDROCHLORIDE

1-PYRIDIN-2-YL-[1,4]DIAZEPANE DIHYDROCHLORIDE

C10H17Cl2N3 (249.0799)


   

6-(benzo[d][1,3]dioxol-5-ylmethyl)-2-thia-6-azaspiro[3.3]heptane

6-(benzo[d][1,3]dioxol-5-ylmethyl)-2-thia-6-azaspiro[3.3]heptane

C13H15NO2S (249.0823)


   

5-NITROSPIRO[BENZIMIDAZOLE-2,1-CYCLOPENTANE] 1,3-DIOXIDE

5-NITROSPIRO[BENZIMIDAZOLE-2,1-CYCLOPENTANE] 1,3-DIOXIDE

C11H11N3O4 (249.075)


   

2-Propenoic acid, 4-cyano[1,1-biphenyl]-4-yl ester

2-Propenoic acid, 4-cyano[1,1-biphenyl]-4-yl ester

C16H11NO2 (249.079)


   

5-(1-METHYL-PYRROLIDIN-2-YL)-PYRIDIN-2-YLAMINEDIHYDROCHLORIDE

5-(1-METHYL-PYRROLIDIN-2-YL)-PYRIDIN-2-YLAMINEDIHYDROCHLORIDE

C10H17Cl2N3 (249.0799)


   

2-Propoxy-5-(trifluoromethyl)pyridine-3-boronic acid

2-Propoxy-5-(trifluoromethyl)pyridine-3-boronic acid

C9H11BF3NO3 (249.0784)


   

1-(2-CYANOPHENYL)METHANESULFONAMIDE

1-(2-CYANOPHENYL)METHANESULFONAMIDE

C13H12FNO3 (249.0801)


   

1-(3-PHENYL-2-PROPENOYL)-1H-BENZOTRIAZO&

1-(3-PHENYL-2-PROPENOYL)-1H-BENZOTRIAZO&

C15H11N3O (249.0902)


   

2-(2-pyridylazo)-1-naphthol

2-(2-pyridylazo)-1-naphthol

C15H11N3O (249.0902)


   

4-hydroxy-2,2:6,2-terpyridine

4-hydroxy-2,2:6,2-terpyridine

C15H11N3O (249.0902)


   

5-nitro-dl-tryptophan

5-nitro-dl-tryptophan

C11H11N3O4 (249.075)


   
   

1,4,5,6-TETRAHYDRO-2-METHYL-6-OXO-4-[4-(FLUORO)PHENYL]-3-PYRIDINECARBOXYLIC ACID

1,4,5,6-TETRAHYDRO-2-METHYL-6-OXO-4-[4-(FLUORO)PHENYL]-3-PYRIDINECARBOXYLIC ACID

C13H12FNO3 (249.0801)


   

bexlosteride

bexlosteride

C14H16ClNO (249.092)


D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006727 - Hormone Antagonists > D065088 - Steroid Synthesis Inhibitors D004791 - Enzyme Inhibitors > D065088 - Steroid Synthesis Inhibitors > D058891 - 5-alpha Reductase Inhibitors C147908 - Hormone Therapy Agent > C547 - Hormone Antagonist > C242 - Anti-Androgen C471 - Enzyme Inhibitor > C2319 - 5 Alpha-Reductase Inhibitor C1892 - Chemopreventive Agent

   
   

6-(chloromethyl)-N-(3-methylphenyl)-1,3,5-triazine-2,4-diamine

6-(chloromethyl)-N-(3-methylphenyl)-1,3,5-triazine-2,4-diamine

C11H12ClN5 (249.0781)


   

N,N-dimethyl-2-[(5-phenyl-1,3,4-oxadiazol-2-yl)thio]ethanamine

N,N-dimethyl-2-[(5-phenyl-1,3,4-oxadiazol-2-yl)thio]ethanamine

C12H15N3OS (249.0936)


   

L-Cysteinyl-L-glutamine

L-Cysteinyl-L-glutamine

C8H15N3O4S (249.0783)


   

N-(4,5-dimethyl-1,3-benzothiazol-2-yl)propanehydrazide

N-(4,5-dimethyl-1,3-benzothiazol-2-yl)propanehydrazide

C12H15N3OS (249.0936)


   

5-(4-Chlorophenyl)-6-ethylpyrimidin-3-ium-2,4-diamine

5-(4-Chlorophenyl)-6-ethylpyrimidin-3-ium-2,4-diamine

C12H14ClN4+ (249.0907)


   

(1E)-1-(3-ethyl-5-methoxy-1,3-benzothiazol-2-ylidene)propan-2-one

(1E)-1-(3-ethyl-5-methoxy-1,3-benzothiazol-2-ylidene)propan-2-one

C13H15NO2S (249.0823)


   

2-amino-9-[5-(hydroxymethyl)-2,5-dihydrofuran-2-yl]-1H-purin-6-one

2-amino-9-[5-(hydroxymethyl)-2,5-dihydrofuran-2-yl]-1H-purin-6-one

C10H11N5O3 (249.0862)


   

N-(2,3-dihydro-1H-inden-1-yl)-N-prop-2-ynylmethanesulfonamide

N-(2,3-dihydro-1H-inden-1-yl)-N-prop-2-ynylmethanesulfonamide

C13H15NO2S (249.0823)


D002491 - Central Nervous System Agents > D018696 - Neuroprotective Agents D004791 - Enzyme Inhibitors > D008996 - Monoamine Oxidase Inhibitors D020011 - Protective Agents

   

N-{2-hydroxy-5-nitrobenzylidene}cyclopropanecarbohydrazide

N-{2-hydroxy-5-nitrobenzylidene}cyclopropanecarbohydrazide

C11H11N3O4 (249.075)


   

8-Quinolinecarboxylic acid phenyl ester

8-Quinolinecarboxylic acid phenyl ester

C16H11NO2 (249.079)


   

8,5-Cyclo-2-deoxyadenosine

8,5-Cyclo-2-deoxyadenosine

C10H11N5O3 (249.0862)


An organic heterotetracyclic compound obtained by intramolecular formation of a C-C bond between positions 8 and 5 of 2-deoxyadenosine.

   

2-(4,5-dihydro-1H-imidazol-2-ylthio)-N-(4-methylphenyl)acetamide

2-(4,5-dihydro-1H-imidazol-2-ylthio)-N-(4-methylphenyl)acetamide

C12H15N3OS (249.0936)


   

Ala-Cys-Gly

Ala-Cys-Gly

C8H15N3O4S (249.0783)


A tripeptide composed of L-alanine, L-cysteine, and glycine joined in sequence by peptide linkages.

   

5-(3-Butoxyphenyl)-1,3,4-thiadiazol-2-amine

5-(3-Butoxyphenyl)-1,3,4-thiadiazol-2-amine

C12H15N3OS (249.0936)


   
   
   

(R)-S(6)-acetyldihydrolipoamide

(R)-S(6)-acetyldihydrolipoamide

C10H19NO2S2 (249.0857)


The (R)-enantiomer of S(6)-acetyldihydrolipoamide.

   

CID 11984887

CID 11984887

C17H14P- (249.0833)


   
   
   
   

5-acetamido-3,5-dideoxy-L-arabino-hept-2-ulopyranosonic acid

5-acetamido-3,5-dideoxy-L-arabino-hept-2-ulopyranosonic acid

C9H15NO7 (249.0848)


   

1H-Indole-2,3-dione, 5-methoxy-1-(trimethylsilyl)-

1H-Indole-2,3-dione, 5-methoxy-1-(trimethylsilyl)-

C12H15NO3Si (249.0821)


   

1-(2-Pyridylazo)-2-naphthol

1-(2-Pyridylazo)-2-naphthol

C15H11N3O (249.0902)


   

cysteinyl-glutamine

cysteinyl-glutamine

C8H15N3O4S (249.0783)


   

L-Glutaminyl-L-cysteine

L-Glutaminyl-L-cysteine

C8H15N3O4S (249.0783)


   

Cysteinyl-Gamma-glutamate

Cysteinyl-Gamma-glutamate

C8H15N3O4S (249.0783)


   

Glutaminylcysteine

Glutaminylcysteine

C8H15N3O4S (249.0783)


   

ML351

ML351

C15H11N3O (249.0902)


ML351 is a potent and highly specific 15-LOX-1 inhibitor with an IC50 of 200 nM. ML351 shows excellent selectivity (>250-fold) versus the related isozymes, 5-LOX, platelet 12-LOX, 15-LOX-2, ovine COX-1, and human COX-2[1].?ML351 prevents dysglycemia and reduces β-cell oxidative stress in nonobese diabetic mouse model of T1D[2].

   

SY-LB-35

SY-LB-35

C15H11N3O (249.0902)


SY-LB-35 is a potent bone morphogenetic protein (BMP) receptor agonist. SY-LB-35 can stimulate significant increases in cell number and cell viability in the C2C12 myoblast cell line, and causes shifts towards the S and G2/M phases of the cell cycle. SY-LB-35 stimulates canonical Smad and non-canonical PI3K/Akt, ERK, p38 and JNK intracellular signaling pathways[1].

   

n-methyl-n-[(2z)-3-(methylsulfanyl)prop-2-enoyl]-2-phenylacetamide

n-methyl-n-[(2z)-3-(methylsulfanyl)prop-2-enoyl]-2-phenylacetamide

C13H15NO2S (249.0823)


   

4,5-dehydroanhydrolycorine

NA

C16H11NO2 (249.079)


{"Ingredient_id": "HBIN009997","Ingredient_name": "4,5-dehydroanhydrolycorine","Alias": "NA","Ingredient_formula": "C16H11NO2","Ingredient_Smile": "NA","Ingredient_weight": "249.26","OB_score": "NA","CAS_id": "212-38-4","SymMap_id": "NA","TCMID_id": "NA","TCMSP_id": "NA","TCM_ID_id": "7921","PubChem_id": "NA","DrugBank_id": "NA"}

   

(2z)-n-methyl-n-[2-(methylsulfanyl)acetyl]-3-phenylprop-2-enamide

(2z)-n-methyl-n-[2-(methylsulfanyl)acetyl]-3-phenylprop-2-enamide

C13H15NO2S (249.0823)


   

(2s)-2-amino-3-(4-nitro-1h-indol-3-yl)propanoic acid

(2s)-2-amino-3-(4-nitro-1h-indol-3-yl)propanoic acid

C11H11N3O4 (249.075)


   

1-(2h-1,3-benzodioxole-5-carbothioyl)piperidine

1-(2h-1,3-benzodioxole-5-carbothioyl)piperidine

C13H15NO2S (249.0823)


   

5,7-dioxa-12-azapentacyclo[10.6.1.0²,¹⁰.0⁴,⁸.0¹⁵,¹⁹]nonadeca-1(19),2,4(8),9,13,15,17-heptaene

5,7-dioxa-12-azapentacyclo[10.6.1.0²,¹⁰.0⁴,⁸.0¹⁵,¹⁹]nonadeca-1(19),2,4(8),9,13,15,17-heptaene

C16H11NO2 (249.079)


   

1-(1h-pyrrol-2-yl)-9h-pyrido[3,4-b]indol-6-ol

1-(1h-pyrrol-2-yl)-9h-pyrido[3,4-b]indol-6-ol

C15H11N3O (249.0902)


   
   

n-methyl-n-[2-(methylsulfanyl)acetyl]-3-phenylprop-2-enamide

n-methyl-n-[2-(methylsulfanyl)acetyl]-3-phenylprop-2-enamide

C13H15NO2S (249.0823)


   

(2e)-n-methyl-n-[2-(methylsulfanyl)acetyl]-3-phenylprop-2-enamide

(2e)-n-methyl-n-[2-(methylsulfanyl)acetyl]-3-phenylprop-2-enamide

C13H15NO2S (249.0823)


   

2-methyl-17-oxa-2-azatetracyclo[8.7.0.0³,⁸.0¹¹,¹⁶]heptadeca-1(10),3,5,7,11(16),12,14-heptaen-9-one

2-methyl-17-oxa-2-azatetracyclo[8.7.0.0³,⁸.0¹¹,¹⁶]heptadeca-1(10),3,5,7,11(16),12,14-heptaen-9-one

C16H11NO2 (249.079)